| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/07/2004 | WO2004025254A3 Food-borne pathogen and spoilage detection device and method |
| 10/07/2004 | WO2004024880A3 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 10/07/2004 | WO2004021999A3 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 10/07/2004 | WO2004018636A3 Methods for modulating transcriptional activation using mint proteins |
| 10/07/2004 | WO2004016765A9 Method for search based character optimization |
| 10/07/2004 | WO2004011426A3 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 10/07/2004 | WO2004010934A3 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 10/07/2004 | WO2004009798A3 Protein interaction difference mapping |
| 10/07/2004 | WO2003101386A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 10/07/2004 | WO2003092581A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 10/07/2004 | WO2003092475A3 Diagnosis and treatment of glaucoma |
| 10/07/2004 | WO2003091446A3 Multi-functional microarrays and methods |
| 10/07/2004 | WO2003091415A3 Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color |
| 10/07/2004 | WO2003084869A3 Method for separating single-wall carbon nanotubes and compositions thereof |
| 10/07/2004 | WO2003076915A8 Method for conducting automated surface inspection and surface correction |
| 10/07/2004 | WO2003072106A8 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 10/07/2004 | WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |
| 10/07/2004 | WO2003062420A8 Molecular libraries |
| 10/07/2004 | WO2003054773A3 Non-linear modelling of biological activity of chemical compounds |
| 10/07/2004 | WO2003035833A3 Modifier of the p53 pathway and methods of use |
| 10/07/2004 | WO2003029431A3 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 10/07/2004 | WO2002092000A3 Hbm variants that modulate bone mass and lipid levels |
| 10/07/2004 | WO2002078636A3 Detection and treatment of colorectal cancer |
| 10/07/2004 | WO2002075278A3 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 10/07/2004 | WO2002068932A3 Methods for providing extended dynamic range in analyte assays |
| 10/07/2004 | WO2002068451A3 Sperm protein 17 for the diagnosis and treatment of cancer |
| 10/07/2004 | WO2002067771A3 Chemokine receptors and disease |
| 10/07/2004 | US20040199934 Transgenic rodents as animal moldels for modulation of b1 bradykinin receptor protein |
| 10/07/2004 | US20040199436 Methods of specifying or identifying particulate material |
| 10/07/2004 | US20040199428 Shopping receptacle with in-built user interface |
| 10/07/2004 | US20040199424 Dynamic user registration |
| 10/07/2004 | US20040199409 Remote health monitoring and maintenance system |
| 10/07/2004 | US20040199280 Robotic assembly |
| 10/07/2004 | US20040199098 Blood collection systems and methods that derive estimated effects upon the donor's blood volume and hematocrit |
| 10/07/2004 | US20040199062 Optical sensor containing particles for in situ measurement of analytes |
| 10/07/2004 | US20040198971 Multisignal labeling reagents, and processes and uses therefor |
| 10/07/2004 | US20040198966 1-{3'-O-benzoyl-4'-O-[(4,4'-dimethoxytriphenyl)methyl]- beta -D-ribopyranosy}thymine preparation using solid phase synthesis |
| 10/07/2004 | US20040198963 Protein having covalently bonded puromycin tag for use as diagnostic tool in proteomics |
| 10/07/2004 | US20040198962 Immunotherapy; antitumor agents |
| 10/07/2004 | US20040198958 Isolating maltose or chitin binding protein from mixture via perfusion of mixture through immobilized ligand carrier conjugate matrix; protein isolation |
| 10/07/2004 | US20040198954 Gram negagtive bacterial polypeptide for use in diagnosis, prevention and treatment of swine respiratory system infection disorders; veterinary medicine; vaccine development |
| 10/07/2004 | US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides |
| 10/07/2004 | US20040198950 Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons |
| 10/07/2004 | US20040198887 Methods of selecting and developing a partculate material |
| 10/07/2004 | US20040198727 Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA damaging treatments |
| 10/07/2004 | US20040198712 Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds |
| 10/07/2004 | US20040198705 Modulation of steroid hormone uptake |
| 10/07/2004 | US20040198703 Protecting groups for biological labeling |
| 10/07/2004 | US20040198686 Administering resistin-like molecules alpha or beta |
| 10/07/2004 | US20040198661 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 10/07/2004 | US20040198659 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 10/07/2004 | US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon |
| 10/07/2004 | US20040198656 Methods of screening molecules that are used to prevent cardiovascular diseases |
| 10/07/2004 | US20040198655 recombinant human ptx3 gene as a drug target and diagnostic marker for fertility drugs |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198649 a VR4 peptide, a VR4 polypeptide modulator, a VR4 polynucleotide, or an antisense agent as analgesics or antiarthritic agents for bone and cartilage disorders; rheumatoid and osteoarthritis, osteoperosis; biodrugs |
| 10/07/2004 | US20040198633 Fungicide against Candida, Entomocorticum, Stereum, Phellinus, Peniophora, Xilaria, Rosellinia, Multiclavula, Hericium, and/or Tricholoma; flucytosine, miconazole,ketoconazole, fluconazole, amphotericin B extracted from culture of Streptomyces and/or nystatin |
| 10/07/2004 | US20040197934 Identifying subgroups of compounds with preferential cellular activities representative of diverse subsets from larger compound database collections; drug screening, design and characterization |
| 10/07/2004 | US20040197932 Biochip comprised of lipocalcins which is utilized in quartz crystal microbalance (QCM) and surface acoustic wave (SAW) devic for use in air quality monitoring, quality control of cosmetics and fermentation products and medical diagnostics via breath analysis |
| 10/07/2004 | US20040197931 Microdevice and method for detecting a characteristic of a fluid |
| 10/07/2004 | US20040197930 Proteomic analysis of biological fluids |
| 10/07/2004 | US20040197928 Method for detecting selective androgen receptor modulators |
| 10/07/2004 | US20040197927 Using mathematical algorithims to ehance absorption spectra and decrease noise in determining concentration of biopolymers in fluids |
| 10/07/2004 | US20040197925 Analysis |
| 10/07/2004 | US20040197924 Providing product consistency using absorption spectrum of particulate materials; quality control and quality assurance |
| 10/07/2004 | US20040197923 Providing product uniformity via maintenance of morphological and interfacial property values of particulate material; quality control and quality assurance |
| 10/07/2004 | US20040197922 Identifying presence of contaminates in fluid distribution system; wastewater treatment; chemical and biosensors; detection of chemical and biological warfare agets |
| 10/07/2004 | US20040197904 Method for separating cells using immunorosettes |
| 10/07/2004 | US20040197899 Biosensor and related method |
| 10/07/2004 | US20040197898 Device for monitoring electrochemical variations associated with biosamples |
| 10/07/2004 | US20040197893 Human double minute proteins (HDM2) for identifying modulator for treatment of cell proliferative disorders |
| 10/07/2004 | US20040197889 cell free hepatitis b virus transcription/translation in escherichia plasmid; enzyme inhibitors; mimetics; viricides; shelf life |
| 10/07/2004 | US20040197872 can be used in single or dual purpose and porcine reproductive respiratory syndrome virus vector vaccines; genetic engineering |
| 10/07/2004 | US20040197871 for diagnosing and treating inflammatory bowel disease using purified polypeptide; genetic engineering |
| 10/07/2004 | US20040197865 for detecting agonists of toll-like receptors/immune response modifier drugs genetic engineering |
| 10/07/2004 | US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering |
| 10/07/2004 | US20040197859 useful for treatment of migraine headaches/prophylaxis, menopausal hot flashes, chronic tension type headache, cluster headache, neurogenic or chronic inflammation, gastrointestinal disorders, type 2 diabetes and cardiovascular disorders |
| 10/07/2004 | US20040197847 High throughput screening assays using fatty acid synthetic enzymes |
| 10/07/2004 | US20040197846 based upon the shape of a glucose profile in response to a stimulus (medication, exercise, or caloric intake); provides rapid feedback of an individual's diabetic state |
| 10/07/2004 | US20040197844 Marker for inflammatory conditions |
| 10/07/2004 | US20040197843 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis |
| 10/07/2004 | US20040197842 for monitoring patients in vitro over time which can reveal changes in risk for hypercoagulation or other coagulopathies and/or effectiveness of anticoagulant therapy |
| 10/07/2004 | US20040197841 Methods and reagents for multiplexed analyses |
| 10/07/2004 | US20040197839 Methods of detecting cancer cells in biological samples |
| 10/07/2004 | US20040197838 for creating this postranslational modification in vivo; genetic engineering; solid phase synthesis; kits |
| 10/07/2004 | US20040197837 Reagent for detecting anti-phospholipid antibody and reagent kit using the same |
| 10/07/2004 | US20040197836 Measurement of F-actin in whole blood cellular subsets |
| 10/07/2004 | US20040197835 Binding of tagged and cleaving probes to cell surface molecules that have formed an oligomeric complex results in release of the molecular tag from the binding compound, providing a measure of formation of the complex; photosensitizers |
| 10/07/2004 | US20040197834 Screening labeled compounds for binding affinity; inducing cell differentiation by contacting with butyric acid, dimethyl sulfoxide, retinoic acid, dibutyryl cyclic-AMP or 5-bromodeoxyuridine |
| 10/07/2004 | US20040197833 Binding of the CBDs (cell binding domain) to a solid phase and contacting with target cells; magnetic hydrophilic beads; hydrolases and lysins; use in detection, diagnosis and immobilization; biochips |
| 10/07/2004 | US20040197832 Immunohistochemical staining, use of human leukocyte antigen specific antibody and fluorescence in situ hybridization for determining fetal gender and/or chromosomal aneuploidy |
| 10/07/2004 | US20040197831 Determining the level in blood or serum and comparing to that of a healthy subject, where a lower concentration indicates the risk Alzheimer's Disease; enzyme-linked immunosorbent assay |
| 10/07/2004 | US20040197830 Diagnostic assay for human matrix Gla-protein and its use as a biomarker |
| 10/07/2004 | US20040197828 Method for diagnosis and treatment of bone turnover |
| 10/07/2004 | US20040197827 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 10/07/2004 | US20040197826 Ionization by matrix-assisted laser desorption; generating in-source decay fragments using high laser energy; fragmentation by gas, surface or photon collisions or metastable decay |
| 10/07/2004 | US20040197824 Method for selective radioactive marking of peptides |
| 10/07/2004 | US20040197823 Compositions and methods for aa4rp assay |
| 10/07/2004 | US20040197821 base member having a conductive electric property, binding agent layer and dielectric element; detecting presence/concentration of analyte by measuring current in circuit |
| 10/07/2004 | US20040197820 Membrane-based apparatus that utilizes conjugated probes that contains a specific binding member which complexes with the analyte; excess undergoes non-specific binding, such as to a hydrophobic domain; reduces false negatives |